Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00653263 · ClinicalTrials.gov registry record
Characterizing Methamphetamine Withdrawal in Recently Abstinent Methamphetamine Users: A Pilot Study
A clinical trial of Methamphetamine-dependence and Methamphetamine Withdrawal, sponsored by University of Arkansas.
- Completed
- Registry status
- 8
- Enrollment target
- 1
- Study location
NCT00653263 is a study of Methamphetamine-dependence and Methamphetamine Withdrawal that has completed, run by University of Arkansas. The registered enrollment target is 8 participants, below the 106-participant average among 18 other Methamphetamine-dependence trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00653263, a study of Methamphetamine-dependence and Methamphetamine Withdrawal, has completed, sponsored by University of Arkansas.
- COMPLETED
- Registry status
- 8 participants
- Enrollment target
- 1
- Study location
Study Summary
Methamphetamine use has escalated in recent years. Methamphetamine use has also spread throughout the country. Although much information has been gathered on the treatment of cocaine abuse, very little information has been obtained on the treatment of methamphetamine abuse. One of the first steps in developing appropriate treatment is to examine the effects of stopping a particular substance's use on individuals abusing that substance. To date this has not been well studied for people abusing methamphetamine. The purpose of this study is to better understand and develop accurate ways of measuring symptoms associated with stopping the use of methamphetamine in people that are abusing methamphetamine. If the withdrawal symptoms are able to be effectively measured, this will help to develop treatments targeted at alleviating these symptoms. These symptoms are often associated with relapse to use of that substance.
Conditions Studied
Study Locations (1)
Arkansas
- University of Arkansas for Medical Sciences - Little Rock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2006-08 |
| Est. Completion | 2008-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00653263
The ClinicalTrials.gov registry entry for NCT00653263 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 106-participant average among 18 other Methamphetamine-dependence trials with a reported enrollment target (92% lower). The listed sponsor is University of Arkansas, which has 318 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Methamphetamine-dependence appearing as the primary indexed condition, and to 0 interventions.
NCT00653263 reports 1 study location spanning 1 distinct geographic area - top geographies include Arkansas.
Frequently Asked Questions
What is clinical trial NCT00653263 about?
NCT00653263 is a clinical study titled "Characterizing Methamphetamine Withdrawal in Recently Abstinent Methamphetamine Users: A Pilot Study". Methamphetamine use has escalated in recent years. Methamphetamine use has also spread throughout the country. Although much information has been gathered on the treatment of cocaine abuse, very little information has been obtained on the treatment of methamphetamine abuse. One of the first steps in...
What is the current status of trial NCT00653263?
This trial is currently completed. The enrollment target is 8 participants. The study started on 2006-08. Estimated completion is 2008-08.
What conditions does trial NCT00653263 study?
This clinical trial studies the following conditions: Methamphetamine-dependence, Methamphetamine Withdrawal.
Who is sponsoring clinical trial NCT00653263?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00653263 being conducted?
This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Methamphetamine-dependence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders
RECRUITING · Phase 2
-
Trial of Naltrexone/Bupropion for the Treatment of Methamphetamine Use Disorder
RECRUITING · Phase 3
-
Encouraging Abstinence Behavior in a Drug Epidemic: Optimizing Dynamic Incentives
RECRUITING · NA
-
rTMS for Craving in Methamphetamine Use Disorder
RECRUITING · NA
-
PRevention Of Methamphetamine Use Among Postpartum Women Trial (PROMPT)
RECRUITING · Early Phase 1
-
Creatine for Depressed Male and Female Methamphetamine Users
RECRUITING · Phase 3
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.